{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:02:48Z","timestamp":1791000168024,"version":"4.1.0"},"reference-count":59,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Scleroderma (morphea) en coup de sabre is a localized subtype restricted to the frontoparietal region of the head. Current treatment paradigms rely on low levels of evidence, primarily case reports and case series-supported by expert opinions. The aim of this article was to systematically analyze current data related to the treatment of localized scleroderma en coup de sabre. The databases Scopus, PubMed, and EBSCO were searched for all reports discussing the treatment of localized scleroderma en coup de sabre. The keywords en coup de sabre, \u201cfacial linear scleroderma\u201d, and \u201cmorphea linearis\u201d, combined with \u201ctreatment\u201d or \u201ctherapy\u201d were used as search terms. A total of 34 articles analyzed treatment outcomes for patients with localized scleroderma en coup de sabre including 4 retrospective cohort studies, 2 prospective cohort studies, 4 case series, and 24 case reports, representing a total of 69 patients (38 children and 31 adults). Methotrexate was the most commonly investigated treatment (26 patients) with a highest response rate (26\/26, 100%). Other treatments included systemic glucocorticosteroids (nine patients), followed by UVA1 (four patients), mycophenolate mofetil (two patients), hydroxychloroquine (five patients), abatacept (two patients), tocilizumab (three patients), cyclosporine (one patient), interferon gamma (one patient), PUVA therapy (two patients), NB-UVB therapy (one patient), and pulsed dye laser (one patient). Reconstructive and surgery treatment was successfully used for lesions with settled disease activity to improve the cosmetic aspect of the lesions. Conclusion: methotrexate is the most often-studied treatment and reported good clinical outcomes in children and adults with localized scleroderma en coup de sabre.<\/jats:p>","DOI":"10.3390\/jcm10194517","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:03:42Z","timestamp":1632960222000},"page":"4517","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Therapeutic and Reconstructive Management Options in Scleroderma (Morphea) en Coup de Sabre in Children and Adults. A Systematic Literature Review"],"prefix":"10.3390","volume":"10","author":[{"given":"Ewelina","family":"Ulc","sequence":"first","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8308-1023","authenticated-orcid":false,"given":"Lidia","family":"Rudnicka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-3589","authenticated-orcid":false,"given":"Anna","family":"Wa\u015bkiel-Burnat","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Warszawik-Hendzel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4447-282X","authenticated-orcid":false,"given":"Anna","family":"Niemczyk","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Olszewska","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: A retrospective review of 54 patients","volume":"56","author":"Tollefson","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/09546634.2017.1341615","article-title":"The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype)","volume":"29","author":"Rattanakaemakorn","year":"2018","journal-title":"J. Dermatolog Treat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fmed.2017.00258","article-title":"Progressive Hemifacial Atrophy and Linear Scleroderma en coup de sabre: A Spectrum of the Same Disease?","volume":"4","author":"Khamaganova","year":"2017","journal-title":"Front. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00417-011-1911-6","article-title":"Linear scleroderma en coup de sabre affecting the upper eyelid and lashes","volume":"250","author":"Mears","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2340\/00015555-2920","article-title":"Localized Scleroderma of the Head and Face Area: A Retrospective Cross-sectional Study of 96 Patients from 5 German Tertiary Referral Centres","volume":"98","author":"Kreuter","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1546-0096-9-18","article-title":"Brain cavernomas associated with en coup de sabre linear scleroderma: Two case reports","volume":"9","author":"Fain","year":"2011","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_7","first-page":"62","article-title":"Atypical Neuroimaging Manifestations of Linear Scleroderma \u201cen coup de sabre\u201d","volume":"9","author":"Allmendinger","year":"2015","journal-title":"Iran. J. Child. Neurol."},{"key":"ref_8","first-page":"654","article-title":"Update on the classification and treatment of localized scleroderma","volume":"104","year":"2013","journal-title":"Actas Dermosifiliogr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1937586717747384","article-title":"How to Write a Systematic Review of the Literature","volume":"11","author":"Pati","year":"2018","journal-title":"Herd"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/j.oooo.2015.02.002","article-title":"A rare cause of gingival recession: Morphea with intra-oral involvement","volume":"119","author":"Hauben","year":"2015","journal-title":"Oral Surg Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.1994.01690050133027","article-title":"Treatment of severe forms of localized scleroderma with oral corticosteroids: Follow-up study on 17 patients","volume":"130","author":"Joly","year":"1994","journal-title":"Arch. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.74.5.661","article-title":"Linear scleroderma \u201cen coup de sabre\u201d coexisting with plaque-morphea: Neuroradiological manifestation and response to corticosteroids","volume":"74","author":"Unterberger","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2340\/00015555-2878","article-title":"Abatacept Improves Skin-score and Reduces Lesions in Patients with Localized Scleroderma: A Case Series","volume":"98","author":"Fage","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1067\/S0190-9622(03)00901-0","article-title":"Scleroderma en coup de sabre with central nervous system and ophthalmologic involvement: Treatment of ocular symptoms with interferon gamma","volume":"49","author":"Obermoser","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13023-019-1015-7","article-title":"Linear scleroderma \u201cen coup de sabre\u201d with extensive brain involvement-Clinicopathologic correlations and response to anti-Interleukin-6 therapy","volume":"14","author":"Magro","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jaad.2019.01.040","article-title":"Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996\u20132013","volume":"80","author":"Kumar","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1365-4632.2010.04843.x","article-title":"Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma","volume":"50","author":"Su","year":"2011","journal-title":"Int. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2002-33488","article-title":"Sklerodermie en coup de sabre: Erfolgreiche Therapie mit topischem Calcipotriol und Medium-Dose UVA1-Phototherapie","volume":"28","author":"Kowalzick","year":"2002","journal-title":"Aktuelle Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D383K6X3TB","article-title":"Familial linear scleroderma (en coup de sabre) responsive to antimalarials and narrowband ultraviolet B therapy","volume":"13","author":"Brownell","year":"2007","journal-title":"Dermatol. Online J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1203475415624912","article-title":"Treatment of Linear Scleroderma (en coup de sabre) With Dermal Fat Grafting","volume":"20","author":"Barin","year":"2016","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/SCS.0b013e3182418ce8","article-title":"Treatment of \u201cen coup de sabre\u201d deformity with adipose-derived regenerative cell-enriched fat graft","volume":"23","author":"Karaaltin","year":"2012","journal-title":"J. Craniofac. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7181\/acfs.2018.01935","article-title":"A surgical approach to linear scleroderma using Medpor and dermal fat graft","volume":"20","author":"Kim","year":"2019","journal-title":"Arch. Craniofac. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1097\/SCS.0b013e31824ef7e8","article-title":"Frontal linear scleroderma: Long-term result in volumetric restoration of the fronto-orbital area by structural fat grafting","volume":"23","author":"Consorti","year":"2012","journal-title":"J. Craniofac. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.otohns.2007.07.037","article-title":"Treatment of linear scleroderma \u201cen coup de sabre\u201d with AlloDerm tissue matrix","volume":"138","author":"Robitschek","year":"2008","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/ijd.12108","article-title":"En coup de sabre morphea treated with hyaluronic acid filler. Report of a case and review of the literature","volume":"54","author":"Thareja","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/DSS.0000000000000143","article-title":"Use of a blunt-tipped microcannula for soft tissue filler injection in the treatment of linear scleroderma (en coup de sabre)","volume":"40","author":"Sivek","year":"2014","journal-title":"Dermatol. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3390\/toxins7083127","article-title":"Botulinum Toxin for Neuropathic Pain: A Review of the Literature","volume":"7","author":"Oh","year":"2015","journal-title":"Toxins"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/DSS.0000000000000812","article-title":"Improvement of \u201cen coup de sabre\u201d Morphea and Associated Headaches with Botulinum Toxin Injections","volume":"42","author":"Rimoin","year":"2016","journal-title":"Dermatol. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2340\/00015555-3155","article-title":"Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma","volume":"99","author":"Hardy","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e1715","DOI":"10.1542\/peds.2014-0019","article-title":"Headaches as a presenting symptom of linear morphea en coup de sabre","volume":"134","author":"Polcari","year":"2014","journal-title":"Pediatrics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1111\/pde.13647","article-title":"Remission of seizures with immunosuppressive therapy in Parry-Romberg syndrome and en coup de sabre linear scleroderma: Case report and brief review of the literature","volume":"35","author":"Anderson","year":"2018","journal-title":"Pediatr. Dermatol."},{"key":"ref_33","first-page":"e315","article-title":"Morphea \u201cen coup de sabre\u201d: An unusual oral presentation","volume":"9","author":"Niklander","year":"2017","journal-title":"J. Clin. Dent."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.5114\/dr.2017.71222","article-title":"Concomitant en coup de sabre and plaque type morphea in the same patient: A rare occurrence","volume":"104","author":"Arif","year":"2017","journal-title":"Dermatol. Rev.\/Przegl\u0105d Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1525-1470.2008.00848.x","article-title":"Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in a young girl","volume":"26","author":"Crespo","year":"2009","journal-title":"Pediatr. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5301\/jsrd.5000259","article-title":"Tocilizumab is a promising treatment option for therapy resistant juvenile localized scleroderma patients","volume":"2","author":"Foeldvari","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.reuma.2018.05.001","article-title":"Scleroderma \u201cen coup de sabre\u201d with Epilepsy and Uveitis Successfully Treated with Tocilizumab","volume":"16","author":"Osminina","year":"2020","journal-title":"Reumatol. Clin."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clindermatol.2013.01.011","article-title":"Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: Facts and controversies","volume":"31","author":"Gambichler","year":"2013","journal-title":"Clin. Dermatol."},{"key":"ref_39","first-page":"165","article-title":"En coup de sabre presenting as a port-wine stain previously treated with pulsed dye laser","volume":"35","author":"Kakimoto","year":"2009","journal-title":"Dermatol. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/jocd.13490","article-title":"Treatment of linear scleroderma \u201cen coup de sabre\u201d with single-stage autologous fat grafting: A case report and review of the literature","volume":"20","author":"Ayoub","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1590\/abd1806-4841.20163867","article-title":"Scleroderma en coup de sabre treated with polymethylmethacrylate\u2014Case report","volume":"91","author":"Franco","year":"2016","journal-title":"An. Bras. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00105-006-1277-6","article-title":"Surgical correction of scleroderma en coup de sabre","volume":"58","author":"Dirschka","year":"2007","journal-title":"Hautarzt"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/00007611-197008000-00017","article-title":"The use of systemic corticosteroids in dermatology","volume":"63","author":"Fine","year":"1970","journal-title":"South. Med. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.0007-0963.2004.05901.x","article-title":"Good response of linear scleroderma in a child to ciclosporin","volume":"150","author":"Strauss","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/jid.2009.164","article-title":"Hydroxychloroquine induces autophagic cell death of human dermal fibroblasts: Implications for treating fibrotic skin diseases","volume":"129","author":"Oikarinen","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatol. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40272-019-00363-5","article-title":"Update on the Systemic Treatment of Pediatric Localized Scleroderma","volume":"21","author":"Foeldvari","year":"2019","journal-title":"Paediatr. Drugs"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01262331","article-title":"Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma","volume":"287","author":"Ihn","year":"1995","journal-title":"Arch. Dermatol. Res."},{"key":"ref_49","first-page":"1917","article-title":"Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma","volume":"27","author":"Nagaoka","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0190-9622(97)80221-6","article-title":"Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma","volume":"36","author":"Hunzelmann","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1468-3083.2007.02576.x","article-title":"Period of remission after treatment with UVA-1 in sclerodermic skin diseases","volume":"22","author":"Kroft","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/DSS.0000000000001507","article-title":"Topical Adjuncts to Pulsed Dye Laser for Treatment of Port Wine Stains: Review of the Literature","volume":"44","author":"Lipner","year":"2018","journal-title":"Dermatol. Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/1346-8138.14161","article-title":"Diagnostic criteria, severity classification and guidelines of localized scleroderma","volume":"45","author":"Asano","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_54","first-page":"441","article-title":"Hyaluronic Acid in Dermatology","volume":"15","author":"Keen","year":"2017","journal-title":"Skinmed"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1524-4725.2009.01216.x","article-title":"Polymethylmethacrylate facial implant: A successful personal experience in Brazil for more than 9 years","volume":"35","author":"Salaro","year":"2009","journal-title":"Dermatol. Surg."},{"key":"ref_56","first-page":"1073","article-title":"Treatment of atrophies secondary to trilinear scleroderma en coup de sabre by autologous tissue cocktail injection","volume":"29","author":"Oh","year":"2003","journal-title":"Dermatol. Surg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/jdv.14458","article-title":"European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes","volume":"31","author":"Knobler","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ddg.12724","article-title":"German guidelines for the diagnosis and therapy of localized scleroderma","volume":"14","author":"Kreuter","year":"2016","journal-title":"J. Dtsch. Dermatol. Ges."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/19\/4517\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:07:23Z","timestamp":1760166443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/19\/4517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":59,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["jcm10194517"],"URL":"https:\/\/doi.org\/10.3390\/jcm10194517","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]}}}